Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Electronic Molecular Pharmacology: The Benzothiadiazine Antihypertensive Agents

II. Multiple Regression Analyses Relating Biological Potency and Electronic Structure

ARNOLD J. WOHL
Molecular Pharmacology May 1970, 6 (3) 195-205;
ARNOLD J. WOHL
Department of Pharmacology, Schering Corporation, Bloomfield, New Jersey, 07003
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Extended Hückel Theory calculations have been carried out on a number of antihypertensive benzothiadiazine-1, 1-dioxides in their preferred tautomeric and conformational structures [A. J. Wohl, Mol. Pharmacol. 6, 189 (1970)] in an attempt to define by multiple regression analyses the electronic and steric factors which quantitatively control biological potency. The results indicate that position 5 in the benzenoid portion of the molecule is a center for receptor-drug electron transfer, determined by the energy of the most energetic occupied molecular orbital. Also of importance is the degree of positive charge localized on atom 4 and the substituent group on position 3, as well as the charge on the sulfone oxygen atoms. An intimate sequence of molecular events comprising the mechanism of action is proposed, and a model of receptor structure is offered which accounts for the competitive behavior of these compounds with Ba++ and Ca++ and is used to predict the potencies of a wide variety of nonselected compounds with high accuracy.

ACKNOWLEDGMENTS The author is deeply indebted to Miss Lorraine M. Hausler and Mrs. Emma Eynon for painstaking collection of pA2 values, to Dr, J. G. Topliss for synthesis of compounds, to Mrs. Margaret Hanks for needed help in interpretation of the regression analyses, and to Mrs. Barbara Uhrmacher for programming assistance. Neither this nor the preceding paper would have been possible without the help of the Quantum Chemical Program Exchange of Indiana University, which supplied the EHT program (QCPE 64) and the program for calculation of Cartesian atomic coordinates as input to the EHT program as PROXYZ (QCPE 94). Special acknowledgments are due Mr. Robert Meese of the Singer-General Precision Corporate Data Center, for help with the operations and scheduling of SRU 1108 computer time.

  • Copyright ©, 1970, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 6, Issue 3
1 May 1970
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Electronic Molecular Pharmacology: The Benzothiadiazine Antihypertensive Agents
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Electronic Molecular Pharmacology: The Benzothiadiazine Antihypertensive Agents

ARNOLD J. WOHL
Molecular Pharmacology May 1, 1970, 6 (3) 195-205;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Electronic Molecular Pharmacology: The Benzothiadiazine Antihypertensive Agents

ARNOLD J. WOHL
Molecular Pharmacology May 1, 1970, 6 (3) 195-205;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • EIPA, HMA and SMN2 gene regulation
  • Clc-2 has minor role in intestinal Cl- secretion
  • Resveratrol acts as an NR4A1 antagonist in lung cancer.
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics